Top Losers: Magnum Hunter Resources Corp (NYSE:MHR), eHealth (NASDAQ:EHTH), Coupons.Com (NYSE:COUP), Relypsa Inc (NASDAQ:RLYP), EDENOR (NYSE:EDN)

Technology Stocks News 19

Magnum Hunter Resources Corp (NYSE:MHR) CEO Gary Evans recently shared with CNBC his belief that convenient location makes these shale deposits extremely promising. “There’s not a better growth story in the United States for gas than the Marcellus and Utica,” Evans said. Magnum Hunter Resources Corp (NYSE:MHR) stock performance was -5.54% in last session and finished the day at $8.35. Traded volume was 6.13million shares in the last session and the average volume of the stock remained 4.08million shares. The beta of the stock remained 1.44. Magnum Hunter Resources Corp (NYSE:MHR) insider ownership is 4.70%.

eHealth, Inc (NASDAQ:EHTH) was downgraded by equities researchers at Jefferies Group from a “buy” rating to a “hold” rating in a research report issued on Tuesday, TheFlyOnTheWall.com reports. eHealth, Inc. (NASDAQ:EHTH) dropped -13.05 percent to $33.91 Tuesday on volume of 1.71million shares. The intra-day range of the stock was $33.02 to $37.49. eHealth, Inc. (NASDAQ:EHTH) has a market capitalization of $645.06million.

Coupons.com Inc. (NYSE:COUP) announced it has released updates to the Coupons.com website and the Coupons.com mobile apps with a service that lets consumers add coupons directly to payment cards. Coupons.Com Inc (NYSE:COUP)’s stock on June 10, 2014 reported a decrease of -10.60% to the closing price of $24.88. Its fifty two weeks range is $15.56 -$33.00. The total market capitalization recorded $1.81billion. The overall volume in the last trading session was 691,730.00million shares. In its share capital, COUP has 77.52million outstanding shares.

Relypsa, Inc. (NASDAQ:RLYP), a biopharmaceutical company, announced it has secured a loan facility of up to $35 million with Oxford Finance LLC (“Oxford”) and Silicon Valley Bank (“SVB”).  Under the terms of the agreement, the company immediately drew $15 million upon closing on May 30, 2014, of which $11 million was used to repay in full the company’s existing debt with Oxford and SVB, leaving the remaining $4 million available for working capital purposes. Payments on the new $15 million will be interest only through April 2015. Upon acceptance of the company’s New Drug Application for patiromer by the U.S. Food and Drug Administration, the interest only payment period will be extended to December 2015 and the company may, at its option, draw an additional $20 million during the second half of 2015. On Tuesday, shares of Relypsa Inc (NASDAQ:RLYP) dropped -7.36% to close the day at $22.91. Company monthly performance is recorded as 16.89%. Relypsa Inc (NASDAQ:RLYP) quarterly revenue growth is -44.66%.

EDENOR S.A. (ADR) (NYSE:EDN) stock performance was -5.35% in last session and finished the day at $12.02. Traded volume was 574,553.00million shares in the last session and the average volume of the stock remained 141.21K shares. The beta of the stock remained 2.13. EDENOR S.A. (ADR) (NYSE:EDN) insider ownership is 0.38%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone